Biogen | LinkedIn (original) (raw)

About us

Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth. With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we have world-class manufacturing facilities in North Carolina and Solothurn, Switzerland. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries. For more information, please visit www.biogen.com. Follow us on social media – LinkedIn, Facebook, X, and YouTube.

Industry

Biotechnology Research

Company size

5,001-10,000 employees

Headquarters

Cambridge, MA

Type

Public Company

Locations

Employees at Biogen

Updates

There are around 5 million people worldwide who are living with lupus, a complex chronic autoimmune disease that can cause pain and inflammation in any part of the body. In partnership with the scientific community, we aim to advance research to address the diverse needs of the lupus community. Learn more about our work: https://ow.ly/8wnI50U86WF #ACR24 | #Lupus
The updates we are sharing at ACR Convergence 2024 represent our ongoing commitment to advancing options that can make a difference in the lives of people living with lupus. Learn more about our long-standing efforts in lupus: https://ow.ly/Wns750U86Pn #ACR24 | #Lupus
With Eisai, we received a positive opinion from the Committee for Medicinal Products for Human Use, part of the European Medicines Agency, in our treatment for Alzheimer's disease (AD). This represents a significant advancement in our commitment to people living with AD. Read more in our news release: https://lnkd.in/daj5mnAk #News | #AlzheimersDisease
Lee Gervitz, our Vice President and Head of North America Medical will be at The Boston Globe’s Future of Medicine event with industry leaders to discuss advancements of Alzheimer’s disease (AD) research and how the healthcare system is evolving to serve people living with AD. Learn more about this event: https://ow.ly/qJOs50U61gN
Nicole has always been passionate about her career in rare diseases, yet she never imagined she would be among the caregiver community, following science from an entirely new and devastating perspective. Click through to read how Nicole and her family are navigating their new normal: https://ow.ly/n4PH50U5En8 #ALS | #NationalFamilyCaregiversMonth | #TeamBiogen
We’ll be at ACR Convergence 2024 in Washington, D.C., sharing more about our work to advance options for people living with lupus. Join us at booth #3937. Learn more: https://ow.ly/OSav50U5hRX #ACR24 | #Lupus
This Veterans Day we honor the individuals who have dedicated their time and energy to preserving our national security. At Biogen, we are committed to supporting colleagues like Peter Mertz, who brings invaluable experience as a veteran to help drive our corporate mission. Watch Peter's story and join us in expressing our gratitude to all veterans and their families for their service and sacrifice. Learn more about how we are committed to building a culture of inclusion and belonging: https://ow.ly/4ohn50U3vVw #VeteransDay | #TeamBiogen
Team Biogen took part in the Alzheimer's Association Walk to End Alzheimer's to raise awareness and hear inspiring stories from community members impacted by this disease. These stories of resilience and courage drive our commitment to combat Alzheimer's disease (AD) and continue pushing forward scientific advancements. See how we’re addressing AD through research and innovation: https://ow.ly/3gfL50U35y5 #TeamBiogen | #ENDALZ | #Walk2EndAlz
With patient safety as the first priority, we recognize the critical role of pharmacovigilance. During this year´s #MedSafetyWeek, we’re emphasizing the importance of using medicines correctly and reporting adverse events when they occur. Learn more about Med Safety Week 2024: https://ow.ly/xHBf50TZFxP #MedSafetyWeek | #PatientSafety

Join now to see what you are missing

Join now

Affiliated pages

Browse jobs

Stock

BIIB

November 16, 2024

NASDAQ

20 minutes delay

Open

165.46

Low

159.6

High

166.34

Data from Refinitiv

See more info on Bing